This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Core Labs' (CLB) Q3 Earnings Beat Estimates, Revenues Miss Mark
by Zacks Equity Research
In the September quarter, Core Labs (CLB) generates $20.7 million in operating cash and its capital expenditure totals $2.2 million, leading to $18.5-million free cash flow (FCF) recognition.
Core Laboratories (CLB) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of 14.29% and -3.20%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Core Laboratories (CLB) in Q3 Earnings?
by Zacks Equity Research
Core Laboratories' (CLB) Production Enhancement unit is expected to have incurred operating loss in Q3, same as the previous quarter.
Factors Setting the Tone for TechnipFMC (FTI) in Q3 Earnings
by Zacks Equity Research
Softness in North American activity due to the coronavirus pandemic, which caused a crude price crash, is expected to have hurt TechnipFMC's (FTI) Surface segment's top line in Q3.
Core Laboratories (CLB) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
Core Laboratories (CLB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Solid Overseas Market Aid Halliburton (HAL) Q3 Earnings?
by Zacks Equity Research
Halliburton's (HAL) impressive cost-controlling measures whereby it intends to lower its 2020 capital budget to almost half at $800 million should drive the company's earnings and cash flows higher.
Oceaneering, US Navy Cut A Deal for Submarine Rescue Systems
by Zacks Equity Research
Oceaneering (OII) seals a deal with U.S. Navy to maintain and manage the Submarine Rescue Systems and provide operative and maintenance support.
Core Laboratories (CLB) Down 0.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
HAL or CLB: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HAL vs. CLB: Which Stock Is the Better Value Option?
USA Compression (USAC) Incurs Wider-Than-Expected Loss in Q2
by Zacks Equity Research
USA Compression Partners' (USAC) adjusted EBITDA inches up 0.7% year over year to $105.5 million on cost-cutting initiatives.
Magellan Midstream (MMP) Q2 Earnings and Sales Lag Estimates
by Zacks Equity Research
Magellan Midstream's (MMP) distributable cash flow (DCF) of $209.5 million in the second quarter drops 33.4% from the year-ago level.
Gulfport Energy (GPOR) Down 19% Post Q2 Earnings Release
by Zacks Equity Research
In Q2, Gulfport Energy's (GPOR) total oil and gas production drops to 93,463 million cubic feet equivalent (MMcfe) from 123,668 MMcfe in the second quarter of 2019.
QEP Resources (QEP) Q2 Loss Wider Than Expected, Sales Miss
by Zacks Equity Research
QEP Resources' (QEP) total operating expenses in the second quarter decline significantly to $233.1 million from $241.7 million a year ago.
Marathon Oil (MRO) Posts Narrower-Than-Expected Loss for Q2
by Zacks Equity Research
In Q2, Marathon Oil's (MRO) average realized liquids prices (crude oil and condensate) of $21.65 per barrel fall the year-earlier level of $59.18.
Transocean's (RIG) Q2 Earnings Break Even, Revenues Rise Y/Y
by Zacks Equity Research
Transocean's (RIG) Ultra-deepwater floaters contribute to 68.4% of its total contract drilling revenues in Q2 while Harsh Environment floaters and Midwater floaters add up the rest.
Oceaneering (OII) Q2 Loss Narrower Than Expected, Sales Miss
by Zacks Equity Research
Oceaneering's (OII) backlog in the Subsea Products segment drops to $486 million as of Jun 30, 2020 from the year-ago backlog of $596 million.
Diamondback (FANG) Q2 Earnings Top Estimates on Solid Output
by Zacks Equity Research
Diamondback's (FANG) Q2 capex adds up to $562 million. The company coughs up $456 million on drilling and completion activity and spends another $32 million on non-operated properties.
Williams (WMB) Q2 Earnings Top Estimates, Revenues Miss
by Zacks Equity Research
Williams' (WMB) total costs and expenses in Q2 decline to $1.17 billion from $1.54 billion a year ago owing to lower product expenses as well as G&A costs.
Nabors' (NBR) Q2 Loss Narrower Than Expected, Sales Miss
by Zacks Equity Research
Nabors' (NBR) total costs and expenses in Q2 fell to $669.5 million from $953.3 million in the year-ago quarter, reflecting lower depreciation costs as well as impairment charges.
Cabot Oil (COG) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Cabot Oil's (COG) total average unit costs rise to $1.44 per thousand cubic feet equivalent from the year-ago figure of $1.41 in Q2.
Concho (CXO) Q2 Earnings Beat Estimates, Revenues Miss Mark
by Zacks Equity Research
As part of its efforts to reduce costs and boost margins, Concho (CXO) succeeds in trimming its controllable expenses by 25% year over year to $7.49 per Boe in Q2.
Apache's (APA) Q2 Loss Narrower Than Expected, Sales Top
by Zacks Equity Research
Apache's (APA) Q2 lease operating expenses of $264 million decline 32% from the year-ago quarter.
TechnipFMC (FTI) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
In the second quarter, TechnipFMC's (FTI) inbound orders plummet 86.3% from the year-ago period to $1.53 billion.
Core Laboratories N.V. (CLB) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Core Laboratories N.V. (CLB).
Core Labs' (CLB) Q2 Earnings and Sales Surpass Estimates
by Zacks Equity Research
In the June quarter, Core Labs (CLB) generates $27 million in operating cash and its capital expenditure totals $3.1 million, leading to $23.9-million free cash flow (FCF) recognition.